A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
Clinical trial NCT06457919 · RECRUITING
Trial details
- NCT number
- NCT06457919
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-04
- Primary completion
- 2027-06-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.